课题基金 / 基金详情

项目摘要

项目成果

JAMES B MITCHELL的其他基金

相似基金

相关文献

中文摘要
翻译
为了改善癌症的治疗,人们对改变辐射损伤给予了相当大的关注。该项目的主要目标是定义和理解肿瘤生理学的这些方面,包括最终确定肿瘤本质的细胞和分子过程,从而使特定剂量的电离辐射在使用时更有效。实现这一目标的一种方法是研究电离辐射与各种化疗药物的相互作用,以评估是否可以使肿瘤更敏感。我们目前的重点是ecinasciin 743和halfuginone。Ecteinascidin表现出抗肿瘤活性,可能是通过鸟嘌呤N2的烷基化导致DNA修复酶的抑制、转录效应和拓扑异构酶的抑制。我们已经观察到,当用相对无毒浓度的卵磷脂预处理人类结肠癌细胞时,辐射反应显著增强。目前正在进行体内研究。哈利福醌是一种TGF β的抑制剂,也对几种人类肿瘤细胞系具有放射致敏作用。这种药剂特别令人感兴趣的是,halfuginone已被证明可以防止正常组织中辐射引起的晚期效应。该项目的另一个主要推力是开发功能成像技术,以更好地表征肿瘤微环境中可能阻止或减少影响辐射反应的药物的重要因素。众所周知,缺氧是辐射敏感性的主要决定因素。因此,我们正在使用几种小鼠肿瘤模型来研究肿瘤缺氧。我们的方法是使用当前的侵入性技术,并将信息扩展到正在开发的非侵入性方法,这样患者的肿瘤治疗概况就可以在个体的基础上进行优化。利用放射生物学分科开发的新型磁共振成像设备,我们最近:a)使用“金标准”氧电极测量验证了肿瘤氧水平的无创Overhauser磁共振成像,b)使用电子顺磁共振成像证明了氮氧化物对羟胺的体内还原率可以产生包括肿瘤在内的各种组织的“氧化还原图”,c)使用双酯氮氧化物/羟胺前体分子证明了“氧化成像”的概念。这项技术可以报道组织氧化作为放射治疗或其他氧化过程的结果。总的来说,这些非侵入性功能成像方法应该增强我们更好地了解肿瘤微环境的能力,并制定有效攻击当前限制癌症治疗方式有效性的潜在障碍的策略。
英文摘要
In the interest of improving cancer treatment, considerable attention has been placed on the modification of radiation damage. The major goal of this project is to define and understand those aspects of tumor physiology, including cellular and molecular processes that ultimately define the very nature of a tumor such that a particular dose of ionizing radiation, when used will be more effective. One means to that end is to investigate the interaction of ionizing radiation with a variety of chemotherapy agents to assess if tumors can be made more sensitive. Our current focus is on ecteinascidin 743 and halifuginone. Ecteinascidin exhibits anti-tumor activity presumably by alkylation of guanine N2 resulting in inhibition of DNA repair enzymes, transcriptional effects, and inhibition of topoisomerases. We have observed significant enhancement of the radiation response when human colon carcinoma cells were pretreated with relatively non-toxic concentrations of ecteinascidin. in vivo studies are presently underway. Halifuginone, an inhibitor of TGF beta, also radiosensitizes several human tumor cell lines. This agent is of particular interest in that halifuginone has been shown to protect against radiation-induced late effects in normal tissues. Another major thrust of this project is to develop functional imaging techniques to better characterize factors important in the tumor microenvironment that may prevent or diminish agents from impacting radiation response. It is well established that hypoxia is a major determinant of radiation sensitivity. Therefore, we are using several murine tumor models to study tumor hypoxia. Our approach is to use current invasive techniques and extend that information to non-invasive methods that are under development, such that patient tumor treatment profiles may optimized on an individual basis. Using novel magnetic resonance imaging equipment developed in the Radiation Biology Branch we have recently: a) validated non-invasive Overhauser magnetic resonance imaging of tumor oxygen levels with "gold standard" oxygen electrode measurements, b) demonstrated using electron paramagnetic resonance imaging that the in vivo reduction rate of the nitroxide to the hydroxylamine can yield a "redox map" of various tissues including tumor, and c) demonstrated the concept of "oxidative imaging" using a double ester nitroxide/hydroxylamine precursor molecule. This technique can report on tissue oxidation as a result of radiation treatment or other oxidative processes. Collectively, these non-invasive functional imaging approaches should enhance our ability to better understand the tumor microenvironment and develop strategies to effectively attack potential barriers that currently limit the effectiveness of cancer treatment modalities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of Therapeutic Response
Radiolysis, Photolysis, Sonolysis and Sonoprotection of
Nitroxides as Protectors Against Oxidative Stress
NITROXIDES AS PROTECTORS AGAINST OXIDATIVE STRESS
海外基金